{
    "nct_id": "NCT04308590",
    "official_title": "Glucocorticoid Receptor Antagonism in the Treatment of Hypercortisolism in Patients With Cortisol-Secreting Adrenal Adenomas or Hyperplasia: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Relacorilant",
    "inclusion_criteria": "* Shows lack of cortisol suppression\n* Suppressed or low early-morning ACTH levels\n* A radiologically confirmed adrenal lesion\n* Has IGT or DM\n* Has uncontrolled hypertension\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 80 Years",
    "exclusion_criteria": "* Has severe, uncontrolled hypertension\n* Has poorly controlled DM\n* Has DM Type 1\n* Has significantly abnormal liver test results or severe renal insufficiency\n* Has uncontrolled, clinically significant hypothyroidism or hyperthyroidism",
    "miscellaneous_criteria": ""
}